169 results on '"Chua, Melvin L.K."'
Search Results
2. A randomized, multicenter, phase II trial of camrelizumab (Cam) with and without metastasis-directed therapy (MDT) in recurrent/metastatic nasopharyngeal carcinoma (R/M-NPC).
3. Effect of tumor-immune microenvironment (TIME) on disparate ascending (A) and descending (D) subtypes of nasopharyngeal carcinoma (NPC).
4. The prognostic value of deep learning-based percentage of tumour-infiltrating lymphocytes in nasopharyngeal carcinoma.
5. Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
6. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population
7. Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer
8. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma
9. Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis
10. Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
11. Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
12. A universal pipeline to combine spatial transcriptomics, proteomics, and diagnostic H&E assays on a single tissue section to study tissue microenvironment.
13. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
14. The metabolic footprint during adipocyte commitment highlights ceramide modulation as an adequate approach for obesity treatment
15. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment
16. Widespread and Functional RNA Circularization in Localized Prostate Cancer
17. Cluster-Based Radiomics Reveal Spatial Heterogeneity of Bevacizumab Response for Treatment of Radiotherapy-induced Cerebral Necrosis
18. Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia
19. 460 International consensus for the target volume delineation for NPC after ICT: First round results
20. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors
21. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
22. Corrigendum to “Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study” [Eur. J. Radiol. Open 11 (2023) 100529]
23. Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
24. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
25. A Prostate Cancer “Nimbosus”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
26. Targeting DNA repair for precision radiotherapy: Balancing the therapeutic ratio
27. Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy
28. A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis
29. Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
30. Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy
31. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
32. Figure S3 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
33. Supplementary Material from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
34. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
35. Germline DNA damage response (DDR) mutations in an East Asian (EA) cohort with prostate cancer (PCa).
36. Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.
37. ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific
38. Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade
39. Matrix metalloproteinase‐1 facilitates MSC migration via cleavage of IGF‐2/IGFBP2 complex
40. Voxel-based radiomics outlines spatial heterogeneity of cerebral radiation necrosis (RN) associated with bevacizumab (Bev) response in head and neck radiotherapy (RT) patients.
41. Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer
42. A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021
43. Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?
44. In Reply to Abbasi et al.
45. Explainable Radiomics Model for the Prediction of Bevacizumab Efficacy in the Treatment of Radiotherapy-Induced Cerebral Necrosis
46. Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck
47. Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
48. An evaluation of concordance between head and neck advanced practice radiation therapist and radiation oncologists in toxicity assessment for nasopharyngeal carcinoma patients
49. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
50. Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.